-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VX9i4A+60sq6fpcnBvawESGHJb5vvwrlhIKjIK+LDFjj8mdHHtHXs4d2v2Dic5LR N9NMvRseTJIv83ITc9DZ3g== 0000950134-00-002068.txt : 20000320 0000950134-00-002068.hdr.sgml : 20000320 ACCESSION NUMBER: 0000950134-00-002068 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000317 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ILEX ONCOLOGY INC CENTRAL INDEX KEY: 0001001915 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-53221 FILM NUMBER: 572898 BUSINESS ADDRESS: STREET 1: 11550 IH-10 WEST SUITE 100 CITY: SAN ANTONIO STATE: TX ZIP: 78230 BUSINESS PHONE: 2109498200 MAIL ADDRESS: STREET 1: 14785 OMICRON DR SUITE 101 CITY: SAN ANTONIO STATE: TX ZIP: 78245 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CTRC RESEARCH FOUNDATION CENTRAL INDEX KEY: 0001059008 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 8122 DATAPOINT DR STREET 2: SUITE 600 CITY: SAN ANTONIO STATE: TX ZIP: 78229 BUSINESS PHONE: 2106165500 MAIL ADDRESS: STREET 1: 8122 DATAPOINT DR STREET 2: SUITE 600 CITY: SAN ANTONIO STATE: TX ZIP: 78229 SC 13G/A 1 AMENDMENT NO. 1 TO SCHEDULE 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1) ILEX ONCOLOGY, INC. ---------------------------------------------------------- (Name of Issuer) COMMON STOCK, PAR VALUE $0.01 ---------------------------------------------------------- (Title of Class of Securities) 451923-10-6 ---------------------------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). [ ] *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 CUSIP No. 451923-10-6 13G Page 2 of 4 Pages - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON CTRC Research Foundation; Tax I.D.: 74-2618443 - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [x] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Texas - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER 2,282,127 NUMBER OF ------------------------------------------------------ SHARES 6. SHARED VOTING POWER BENEFICIALLY OWNED BY None EACH ------------------------------------------------------ REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH 2,282,127 ----------------------------------------------------- 8. SHARED DISPOSITIVE POWER None - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,282,127 - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.5% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS 3 CUSIP No. 451923-10-6 13G Page 3 of 4 Pages ITEM 1. (a) (b) This statement on Schedule 13G relates to the Reporting Person's (as defined in Item 2 below) beneficial ownership interest in ILEX Oncology, Inc., a Delaware corporation (the "Issuer"). The address of the principal executive office of the Issuer is 11550 I.H. 10 West, Suite 300, San Antonio, Texas 78230. ITEM 2. (a) This statement is being filed by CTRC Research Foundation (the "Reporting Person"); (b) The principal business address of the Reporting Person is 8122 Datapoint Drive, Suite 600, San Antonio, Texas 78229. (d) (e) This statement relates to the Common Stock, par value $0.01 per share (the "Common Stock"), of the Issuer named in Item 1 of this statement. The CUSIP number associated with such Common Stock is 451923-10-6. ITEM 3. FILING PURSUANT TO RULE 13d-1(b), OR 13d-2(b). This statement is not being filed pursuant to Rule 13d-1(b) or 13d-2(b). ITEM 4. OWNERSHIP. (a) (b) The aggregate number of shares of the Common Stock beneficially owned by the Reporting Person is 2,282,127, which represents 10.5% of the shares of Common Stock reported to be outstanding as of January 31, 2000. The aggregate number and percentage of the Common Stock beneficially owned by the Reporting Person is calculated in accordance with Rule 13d-3(d)(1). (c) The Reporting Person has sole voting and dispositive power over the Common Stock beneficially owned by it as indicated above. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not Applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not Applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not Applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not Applicable. 4 CUSIP No. 451923-10-6 13G Page 4 of 4 Pages ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not Applicable. ITEM 10. CERTIFICATION. Not Applicable. SIGNATURE After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. March 16, 2000 CTRC RESEARCH FOUNDATION By: /s/ David C. Spoor ---------------------------------------- David C. Spoor, Vice President and General Counsel -----END PRIVACY-ENHANCED MESSAGE-----